Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism

Weiwei Huang1, Qishu Zhang1, Weiran Li1

  • 1Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.

Insights

Novel antibiotic-loaded outer membrane vesicles (OMVs) combat bacterial infections by targeting pathogens directly. This approach reduces toxicity and bacterial drug resistance, offering a promising new strategy for antibacterial drug development.

Area of Science:

  • Biotechnology
  • Microbiology
  • Drug Delivery Systems

Background:

  • Conventional antibiotics face challenges with low efficacy at infection sites, leading to increased toxicity and bacterial drug resistance.
  • Bacterial outer membrane vesicles (OMVs) are implicated in antibiotic resistance mechanisms.
  • Developing targeted drug delivery systems is crucial for enhancing antibacterial efficacy and minimizing side effects.

Purpose of the Study:

  • To investigate the role of bacterial outer membrane vesicles (OMVs) in antibiotic resistance.
  • To design and develop novel antibiotic-loaded OMVs for targeted antibacterial therapy.
  • To evaluate the efficacy and safety of antibiotic-loaded OMVs in vitro and in vivo.

Main Methods:

  • Identification of a novel antibiotic resistance mechanism mediated by bacterial OMVs.
  • Engineering of OMVs to encapsulate and deliver antibiotics.
  • In vitro testing of antibiotic-loaded OMVs against pathogenic bacteria.
  • In vivo studies using a mouse model of intestinal bacterial infection.
  • Assessment of drug retention, systemic spread, bacterial load reduction, and biocompatibility.

Main Results:

  • Antibiotic-loaded OMVs demonstrated effective killing of pathogenic bacteria in vitro.
  • In a mouse model, a single oral dose of antibiotic-loaded OMVs showed sustained intestinal drug retention (36 h) without systemic spread.
  • Significant reduction in bacterial load was observed in the small intestine and feces of infected mice.
  • Safety experiments confirmed excellent biocompatibility of the antibiotic-loaded OMVs.

Conclusions:

  • This study successfully engineered antibiotic-loaded OMVs, leveraging a newly identified resistance mechanism.
  • The developed OMVs provide a targeted and effective strategy for combating bacterial infections, reducing drug resistance.
  • This research expands the therapeutic applications of OMVs and offers innovative approaches for future antibacterial drug development.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
948
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
2.7K
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.3K